Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03475953 |
|---|---|
| Brief Title: | A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors (REGOMUNE) |
| First Submitted : | February 20, 2018 |
| First Submitted that Met QC Criteria : | March 16, 2018 |
| First Posted : | March 23, 2018 |
| Last Update Submitted that Met QC Criteria : | March 2, 2023 |
| Last Update Posted : | March 3, 2023 |